Literature DB >> 29666339

Phenotypic characterization of derivative 22 syndrome: case series and review.

Deepti Saxena1, Priyanka Srivastava, Moni Tuteja, Kausik Mandal, Shubha R Phadke.   

Abstract

Emanuel syndrome is caused due to an additional derivative chromosome 22 and is characterized by severe intellectual disability, microcephaly, failure to thrive, preauricular tags or pits, ear anomalies, cleft or high-arched palate, micrognathia, kidney abnormalities, congenital heart defects and genital abnormalities in males. In 99% of the cases, one of the parents is a carrier of balanced translocation between chromosomes 11 and 22. It occurs due to malsegregation of the gametes with 3:1 segregation. In this case series, we describe four patients with diverse manifestations of this condition. The craniosynostosis observed in one case is a novel finding which has never been reported previously. This study aims to widen the phenotypic spectrum of Emanuel syndrome and provide cytogenetic microarray based breakpoints in two of the cases, thus supporting close clustering of the breakpoints of this common recurrent chromosomal rearrangement.

Entities:  

Mesh:

Year:  2018        PMID: 29666339

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  14 in total

1.  Long AT-rich palindromes and the constitutional t(11;22) breakpoint.

Authors:  H Kurahashi; B S Emanuel
Journal:  Hum Mol Genet       Date:  2001-11-01       Impact factor: 6.150

Review 2.  Prevalence of Emanuel syndrome: theoretical frequency and surveillance result.

Authors:  Tamae Ohye; Hidehito Inagaki; Takema Kato; Makiko Tsutsumi; Hiroki Kurahashi
Journal:  Pediatr Int       Date:  2014-08       Impact factor: 1.524

3.  The 11q;22q translocation: a European collaborative analysis of 43 cases.

Authors:  M Fraccaro; J Lindsten; C E Ford; L Iselius
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

Review 4.  Phenotypic variability of the cat eye syndrome. Case report and review of the literature.

Authors:  P R Rosias; J M Sijstermans; P M Theunissen; C F Pulles-Heintzberger; C E De Die-Smulders; J J Engelen; S B Van Der Meer
Journal:  Genet Couns       Date:  2001

5.  Supernumerary marker chromosomes in man: parental origin, mosaicism and maternal age revisited.

Authors:  John A Crolla; Sheila A Youings; Sarah Ennis; Patricia A Jacobs
Journal:  Eur J Hum Genet       Date:  2005-02       Impact factor: 4.246

Review 6.  Cerebral defects confirm midline developmental field disturbances in supernumerary der(22), t(11;22) syndrome.

Authors:  R Pallotta; P Fusilli; T Ehresmann; R Cinti; A Verrotti; G Morgese
Journal:  Clin Genet       Date:  1996-11       Impact factor: 4.438

7.  Phenotypic delineation of Emanuel syndrome (supernumerary derivative 22 syndrome): Clinical features of 63 individuals.

Authors:  Melissa T Carter; Stephanie A St Pierre; Elaine H Zackai; Beverly S Emanuel; Kym M Boycott
Journal:  Am J Med Genet A       Date:  2009-08       Impact factor: 2.802

8.  Congenital heart disease in supernumerary der(22),t(11;22) syndrome.

Authors:  A E Lin; J Bernar; A J Chin; R S Sparkes; B S Emanuel; E H Zackai
Journal:  Clin Genet       Date:  1986-04       Impact factor: 4.438

9.  Supernumerary chromosome marker Der(22)t(11;22) resulting from a maternal balanced translocation.

Authors:  Jia-Woei Hou
Journal:  Chang Gung Med J       Date:  2003-01

10.  Emanuel syndrome: A rare disorder that is often confused with Kabuki syndrome.

Authors:  Shailendra Kapoor
Journal:  J Pediatr Neurosci       Date:  2015 Apr-Jun
View more
  2 in total

1.  Supernumerary derivative 22 chromosome resulting from novel constitutional non-Robertsonian translocation: t(20;22)-Case Report.

Authors:  H C Manju; Supriya Bevinakoppamath; Deepa Bhat; Akila Prashant; Jayaram S Kadandale; P V V Gowri Sairam
Journal:  Mol Cytogenet       Date:  2022-03-26       Impact factor: 2.009

2.  Non-invasive prenatal screening for Emanuel syndrome.

Authors:  Yuqin Luo; Jie Lin; Yixi Sun; Yeqing Qian; Liya Wang; Min Chen; Minyue Dong; Fan Jin
Journal:  Mol Cytogenet       Date:  2020-03-04       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.